Myriad Genetics Reports Fiscal First-Quarter 2020 Financial Results

NEXT STORY
Merus N.V. Announces Proposed Underwritten Public Offering of Common Shares
PREV STORY
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma to Host Business Update Call and Webcast

author_avatar
NASDAQ Market News

Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS)

author_avatar
NASDAQ Market News

Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance

author_avatar
NASDAQ Market News